中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    TYRUKO (natalizumab-sztn) injection
    TYRUKO (natalizumab-sztn) injection
    departments：肿瘤科
    drug：注射剂
    Active：NATALIZUMAB-SZTN
    indication：用于治疗多发性硬化症
    Licensor：Sandoz, Inc.
    Approved Country/Region：美国
    Approval time：2023-08-24